Evolution of cell therapy for renal cell carcinoma
Abstract Treatment for renal cell carcinoma (RCC) has improved dramatically over the last
decade, shifting from high-dose cytokine therapy in combination with surgical resection of …
decade, shifting from high-dose cytokine therapy in combination with surgical resection of …
Novel Immune Therapies for Renal Cell Carcinoma: Looking Beyond the Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Axes
Novel Immune Therapies for Renal Cell Carcinoma - Hematology/Oncology Clinics Skip to
Main Content Advertisement Hematology/Oncology Clinics Log in Register Log in Subscribe …
Main Content Advertisement Hematology/Oncology Clinics Log in Register Log in Subscribe …
Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects
One of the major hurdles that has hindered the success of chimeric antigen receptor (CAR) T
cell therapies against solid tumors is on-target off-tumor (OTOT) toxicity due to sharing of the …
cell therapies against solid tumors is on-target off-tumor (OTOT) toxicity due to sharing of the …
The 5th Kidney Cancer Research Summit: Research Accelerating Cures for Renal Cell Carcinoma in 2023
Abstract The 5th Kidney Cancer Research Summit was a hybrid event hosted in Boston, MA
in July 2023. As in previous editions, the conference attracted a wide representation of …
in July 2023. As in previous editions, the conference attracted a wide representation of …
Achievements, Challenges, And Limitations Of Car-T Cell Therapy In Cancer Treatment, A Comprehensive Review
A Tahavvori, F Alizadeh, A Mousavian… - Journal of …, 2022 - pnrjournal.com
Chimeric antigen receptor (CAR)-T cell is a novel and promising therapy strategy for
numerous malignant neoplasms management, specifically relapsing or refractory B cell …
numerous malignant neoplasms management, specifically relapsing or refractory B cell …
[HTML][HTML] Engineered T-Cell Therapy: The Next Direction for RCC Immuno-oncology?
JJH Zhang, NA Patel, A Drakaki, AJ Pantuck - kidney-cancer-journal.com
Synthetic biology in the form of engineered antigen specific T-cells for cancer
immunotherapy has demonstrated its potential to revolutionize cancer treatment. However …
immunotherapy has demonstrated its potential to revolutionize cancer treatment. However …